Circ Heart Fail:HbA1c水平可以预测T2DM心衰事件发生率

2015-01-27 沐晴 译 MedSci原创

2型糖尿病目前公认的独立于冠状动脉粥样硬化性疾病和高血压病的发生心衰的独立风险因素, 且血糖控制水平会影响心衰发生率。高血糖会加重心肌损伤,同时上调肾素-血管紧张素-醛固酮系统,增加氧化应激。高血糖症也与心肌细胞脂毒性、线粒体功能障碍、钙处理受损等有关,流行病学证据,证明HbA1c与心衰发生风险相关。但是尚无具体的研究来评估T2DM心衰发生率和血糖控制水平之间的关系。最近,来自英国的Helen M

2型糖尿病目前公认的独立于冠状动脉粥样硬化性疾病和高血压病的发生心衰的独立风险因素, 且血糖控制水平会影响心衰发生率。高血糖会加重心肌损伤,同时上调肾素-血管紧张素-醛固酮系统,增加氧化应激。高血糖症也与心肌细胞脂毒性、线粒体功能障碍、钙处理受损等有关,流行病学证据,证明HbA1c与心衰发生风险相关。但是尚无具体的研究来评估T2DM心衰发生率和血糖控制水平之间的关系。


最近,来自英国的Helen M.Parry等人,为了验证HbA1c的水平对T2DM心衰事件发生的影响,从泰赛德区糖尿病的统计研究数据中选取8783名2型糖尿病患者,进行了一项回顾性的队列研究。通过筛查门诊处方、住院资料和超声心动图报告,来筛查1998年至2011发生的T2DM患者的心衰事件。搜集所有随访者从实验开始到心衰事件发生或者研究终期,所测定的HbA1c值,制作成时间依赖性的HbA1c曲线模型。使用比例风险回归模型,评估与心衰有关的风险因素或疾病,如:血压、体重指数、冠状动脉粥样硬化疾病。

平均5.5±2.8年的随访结果显示,有701名T2DM患者((8%)发生心衰。关于HbA1c纵向时间相关分析结果显示,HbA1c<6%和HbA1c> 10%都是心衰事件发生的独立风险因素。

因此,研究者认为,高或低的HbA1c都可以预测心衰的发生,并且HbA1c和心衰发生的关系呈现U形曲线。有趣的是,先前Currie等人从美国全科医师研究库中选U取的T2DM患者,最终结果显示T2DM的死亡率和心血管意外事件的发生率呈U型曲线。他们证明7.5%HbA1c水平与最低的全因死亡率和最低的大血管意外(心梗、休克、冠脉血管重现或贫血)有关。

原始出处:

Parry HM1, Desmukh H2, Levin D2, Van Zuydam N2, Elder DH2, Morris AD2, Struthers AD2, Palmer CN2, Doney AS2, Lang CC2.Both High and Low HbA1c Predict Incident Heart Failure in Type 2 Diabetes Mellitus.Circ Heart Fail. 2015 Jan 5. pii: CIRCHEARTFAILURE.113.000920. [Epub ahead of print]


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1826270, encodeId=600718262e054, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Feb 17 07:52:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015896, encodeId=78d0201589607, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 24 22:52:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20410, encodeId=04d92041035, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:50:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16234, encodeId=9d0116234db, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:59:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355960, encodeId=13ac135596066, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562287, encodeId=0a9d156228ead, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14749, encodeId=7cc514e4913, content=高糖化毒性?, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Jan 27 18:20:00 CST 2015, time=2015-01-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1826270, encodeId=600718262e054, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Feb 17 07:52:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015896, encodeId=78d0201589607, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 24 22:52:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20410, encodeId=04d92041035, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:50:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16234, encodeId=9d0116234db, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:59:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355960, encodeId=13ac135596066, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562287, encodeId=0a9d156228ead, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14749, encodeId=7cc514e4913, content=高糖化毒性?, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Jan 27 18:20:00 CST 2015, time=2015-01-27, status=1, ipAttribution=)]
    2015-11-24 Smile2680
  3. [GetPortalCommentsPageByObjectIdResponse(id=1826270, encodeId=600718262e054, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Feb 17 07:52:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015896, encodeId=78d0201589607, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 24 22:52:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20410, encodeId=04d92041035, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:50:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16234, encodeId=9d0116234db, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:59:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355960, encodeId=13ac135596066, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562287, encodeId=0a9d156228ead, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14749, encodeId=7cc514e4913, content=高糖化毒性?, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Jan 27 18:20:00 CST 2015, time=2015-01-27, status=1, ipAttribution=)]
    2015-04-11 x35042875

    AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1826270, encodeId=600718262e054, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Feb 17 07:52:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015896, encodeId=78d0201589607, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 24 22:52:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20410, encodeId=04d92041035, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:50:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16234, encodeId=9d0116234db, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:59:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355960, encodeId=13ac135596066, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562287, encodeId=0a9d156228ead, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14749, encodeId=7cc514e4913, content=高糖化毒性?, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Jan 27 18:20:00 CST 2015, time=2015-01-27, status=1, ipAttribution=)]
    2015-02-17 chinayinhan

    已阅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1826270, encodeId=600718262e054, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Feb 17 07:52:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015896, encodeId=78d0201589607, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 24 22:52:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20410, encodeId=04d92041035, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:50:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16234, encodeId=9d0116234db, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:59:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355960, encodeId=13ac135596066, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562287, encodeId=0a9d156228ead, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14749, encodeId=7cc514e4913, content=高糖化毒性?, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Jan 27 18:20:00 CST 2015, time=2015-01-27, status=1, ipAttribution=)]
    2015-01-29 zhaojie88
  6. [GetPortalCommentsPageByObjectIdResponse(id=1826270, encodeId=600718262e054, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Feb 17 07:52:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015896, encodeId=78d0201589607, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 24 22:52:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20410, encodeId=04d92041035, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:50:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16234, encodeId=9d0116234db, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:59:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355960, encodeId=13ac135596066, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562287, encodeId=0a9d156228ead, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14749, encodeId=7cc514e4913, content=高糖化毒性?, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Jan 27 18:20:00 CST 2015, time=2015-01-27, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1826270, encodeId=600718262e054, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Feb 17 07:52:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015896, encodeId=78d0201589607, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 24 22:52:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20410, encodeId=04d92041035, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:50:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16234, encodeId=9d0116234db, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:59:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355960, encodeId=13ac135596066, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562287, encodeId=0a9d156228ead, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Jan 29 02:52:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14749, encodeId=7cc514e4913, content=高糖化毒性?, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Jan 27 18:20:00 CST 2015, time=2015-01-27, status=1, ipAttribution=)]
    2015-01-27 223.104.5.**

    高糖化毒性?

    0

相关资讯

JDI:睾丸激素水平低与2型糖尿病不良结果有关联

对于2型糖尿病男性患者,低血清睾酮似乎与不良临床结果密切相关,根据刊登于Journal of Diabetes Investigation杂志上的一则研究揭示。 该研究的主要领导者Kitty Kit Ting Cheung和同事们进行文献系统回顾研究,研究2型糖尿病患者低血清睾酮水平的证据。作者研究血清睾酮水平对心血管危险因素,代谢综合征和不良临床结果的影响。 研究人员指出,有越来越多的证据发

MCP:中科院科学家揭示蛋白质丙二酰化修饰与2型糖尿病的相关性

随着人们生活水平的提高,糖尿病已经成为所有人不得不正视的问题。然而,经过这么多年的研究,科学家尚未能彻底了解清楚糖尿病的完整机理。 2015年1月1日,中科院杨福愉、杨福全等人发布在Molecular & Cellular Proteomics发表了题为“Lysine malonylation is elevated in type 2 diabetic mouse models and

JAMA:二甲双胍在2型糖尿病和肾脏疾病中的应用

普遍认为,二甲双胍是首选的治疗2型糖尿病的口服降糖药物。但是,由于其有导致乳酸酸中毒的风险,一直禁用于合并严重肾脏疾病的糖尿病患者。最近发表在JAMA上一篇文章,系统的评价合并严重肾脏疾病的糖尿病患者使用二甲双胍,出现乳酸酸中毒的风险。文章搜索了MEDLINE和 Cochrane两个数据库中,从1950年到2014年6月,所有关于二甲双胍,肾脏疾病,乳酸酸中毒的英文文献。排除了综述、快报、评论、案

NEJM:2型糖尿病 外科治疗PK内科治疗

1980 年,Pories 等行胃旁路手术治疗肥胖症时发现,合并T2DM 的病人术后血糖迅速恢复正常,甚至部分病人可不再服用降糖药物。2004 年,Ferchak 等通过前瞻性对照研究发现,合并T2DM 的肥胖病人在接受胃旁路手术后,不需要药物降糖并能长期保持血糖正常的病例数明显高于非手术组,且糖尿病相关并发症的发生率和病死率明显降低。Arterburn 等还发现病人术后出现了收缩压降低、血脂异常

Diabetes Care:吸烟与2型糖尿病长期风险研究(欧洲人群EPIC-InterAct研究)

研究者对吸烟和2型糖尿病发生之间的关系进行了研究,对于大量的潜在混合因素进行分析,并探讨了潜在的效应修饰和中介因素。研究表明,与不吸烟的男性和女性相比,曾经吸烟和目前吸烟是2型糖尿病的发生相关的高风险因素,其独立于教育水平、体力活动、饮酒、饮食。因此,吸烟可作为2型糖尿病的一个危险因素,应鼓励戒烟预防糖尿病。本研究结果发表于最新一期《糖尿病治疗》上(Diabetes Care December 2

Medscape:肥胖会减寿8年

研究者预计,非常胖的人比体重正常者患糖尿病和心血管疾病的时间早了20年,并且比正常人少活8年。研究作者Steven A Grover医生说:“我们的这项发现是由临床意义的,在医生与患者谈论健康的生活方式有何益处时,可以引用此数据。也就是说,体重越重、年纪越轻的人,超重对健康的影响就越大。”该研究发表于近日的Lancet Diabetes & Endocrinology上。研究者评估了20-